Table 3.
Virological response of studied patients.
| Time | SVR | 95% CI |
|---|---|---|
| End of treatment response | 103/103 (100.0%) | 100.0–100.0 |
| Sustained virological response (12 weeks after treatment) | 100/103 (97.1%) | 93.2–100.0 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.